Logo image of CHX

CHAMPIONX CORP (CHX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CHX - US15872M1045 - Common Stock

25.81 USD
-0.79 (-2.97%)
Last: 7/15/2025, 8:00:00 PM
25.83 USD
+0.02 (+0.08%)
After Hours: 7/15/2025, 8:00:00 PM
Fundamental Rating

6

Taking everything into account, CHX scores 6 out of 10 in our fundamental rating. CHX was compared to 62 industry peers in the Energy Equipment & Services industry. Both the health and profitability get an excellent rating, making CHX a very profitable company, without any liquidiy or solvency issues. CHX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • CHX had positive earnings in the past year.
  • In the past year CHX had a positive cash flow from operations.
  • Of the past 5 years CHX 4 years were profitable.
  • In the past 5 years CHX always reported a positive cash flow from operatings.
CHX Yearly Net Income VS EBIT VS OCF VS FCFCHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

  • With a decent Return On Assets value of 8.37%, CHX is doing good in the industry, outperforming 79.03% of the companies in the same industry.
  • CHX has a Return On Equity of 15.29%. This is in the better half of the industry: CHX outperforms 77.42% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 14.15%, CHX belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CHX is in line with the industry average of 12.77%.
  • The last Return On Invested Capital (14.15%) for CHX is above the 3 year average (13.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROIC 14.15%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
CHX Yearly ROA, ROE, ROICCHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • The Profit Margin of CHX (8.20%) is better than 66.13% of its industry peers.
  • CHX's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 14.41%, CHX is doing good in the industry, outperforming 72.58% of the companies in the same industry.
  • CHX's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 33.16%, CHX is in the better half of the industry, outperforming 62.90% of the companies in the same industry.
  • CHX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
CHX Yearly Profit, Operating, Gross MarginsCHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHX is creating some value.
  • The number of shares outstanding for CHX has been reduced compared to 1 year ago.
  • The number of shares outstanding for CHX has been increased compared to 5 years ago.
  • The debt/assets ratio for CHX has been reduced compared to a year ago.
CHX Yearly Shares OutstandingCHX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CHX Yearly Total Debt VS Total AssetsCHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • CHX has an Altman-Z score of 3.65. This indicates that CHX is financially healthy and has little risk of bankruptcy at the moment.
  • CHX has a Altman-Z score of 3.65. This is amongst the best in the industry. CHX outperforms 85.48% of its industry peers.
  • The Debt to FCF ratio of CHX is 1.74, which is an excellent value as it means it would take CHX, only 1.74 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CHX (1.74) is better than 80.65% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that CHX is not too dependend on debt financing.
  • CHX's Debt to Equity ratio of 0.31 is fine compared to the rest of the industry. CHX outperforms 61.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Altman-Z 3.65
ROIC/WACC1.51
WACC9.37%
CHX Yearly LT Debt VS Equity VS FCFCHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 2.25 indicates that CHX has no problem at all paying its short term obligations.
  • CHX has a Current ratio of 2.25. This is in the better half of the industry: CHX outperforms 67.74% of its industry peers.
  • A Quick Ratio of 1.62 indicates that CHX should not have too much problems paying its short term obligations.
  • CHX has a Quick ratio of 1.62. This is in the better half of the industry: CHX outperforms 61.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.62
CHX Yearly Current Assets VS Current LiabilitesCHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

  • The earnings per share for CHX have decreased by -1.63% in the last year.
  • The Earnings Per Share has been growing by 11.09% on average over the past years. This is quite good.
  • Looking at the last year, CHX shows a decrease in Revenue. The Revenue has decreased by -4.17% in the last year.
  • CHX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.29% yearly.
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.80% on average over the next years.
  • CHX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.82% yearly.
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHX Yearly Revenue VS EstimatesCHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
CHX Yearly EPS VS EstimatesCHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.26, CHX is valued correctly.
  • Based on the Price/Earnings ratio, CHX is valued a bit cheaper than the industry average as 64.52% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.38, CHX is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 13.24, CHX is valued correctly.
  • CHX's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 24.29. CHX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.26
Fwd PE 13.24
CHX Price Earnings VS Forward Price EarningsCHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • CHX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CHX.
Industry RankSector Rank
P/FCF 14.43
EV/EBITDA 6.58
CHX Per share dataCHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CHX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.24
PEG (5Y)1.29
EPS Next 2Y3.8%
EPS Next 3Y5.08%

3

5. Dividend

5.1 Amount

  • CHX has a Yearly Dividend Yield of 1.47%. Purely for dividend investing, there may be better candidates out there.
  • CHX's Dividend Yield is a higher than the industry average which is at 1.17.
  • CHX's Dividend Yield is slightly below the S&P500 average, which is at 1.85.
Industry RankSector Rank
Dividend Yield 1.47%

5.2 History

  • The dividend of CHX decreases each year by -47.78%.
  • CHX has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)-47.78%
Div Incr Years2
Div Non Decr Years2
CHX Yearly Dividends per shareCHX Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

  • CHX pays out 24.70% of its income as dividend. This is a sustainable payout ratio.
DP24.7%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
CHX Yearly Income VS Free CF VS DividendCHX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
CHX Dividend Payout.CHX Dividend Payout, showing the Payout Ratio.CHX Dividend Payout.PayoutRetained Earnings

CHAMPIONX CORP

NASDAQ:CHX (7/15/2025, 8:00:00 PM)

After market: 25.83 +0.02 (+0.08%)

25.81

-0.79 (-2.97%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-18
Earnings (Next)10-21
Inst Owners95.44%
Inst Owner Change-0.42%
Ins Owners0.99%
Ins Owner Change0%
Market Cap4.94B
Revenue(TTM)3.58B
Net Income(TTM)293.14M
Analysts86.67
Price Target42.23 (63.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.47%
Yearly Dividend0.37
Dividend Growth(5Y)-47.78%
DP24.7%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)0.36%
Max EPS beat(2)14.53%
EPS beat(4)2
Avg EPS beat(4)-2.36%
Min EPS beat(4)-19.69%
Max EPS beat(4)14.53%
EPS beat(8)4
Avg EPS beat(8)0.56%
EPS beat(12)8
Avg EPS beat(12)1.75%
EPS beat(16)11
Avg EPS beat(16)1.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-1.16%
Revenue beat(4)0
Avg Revenue beat(4)-4.29%
Min Revenue beat(4)-7.8%
Max Revenue beat(4)-1.16%
Revenue beat(8)0
Avg Revenue beat(8)-3.77%
Revenue beat(12)2
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)-1.9%
EPS NQ rev (1m)-2.98%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)-6.47%
EPS NY rev (3m)-10.47%
Revenue NQ rev (1m)-1.62%
Revenue NQ rev (3m)-4.6%
Revenue NY rev (1m)-2.24%
Revenue NY rev (3m)-7.4%
Valuation
Industry RankSector Rank
PE 14.26
Fwd PE 13.24
P/S 1.38
P/FCF 14.43
P/OCF 10.23
P/B 2.58
P/tB 4.71
EV/EBITDA 6.58
EPS(TTM)1.81
EY7.01%
EPS(NY)1.95
Fwd EY7.56%
FCF(TTM)1.79
FCFY6.93%
OCF(TTM)2.52
OCFY9.77%
SpS18.68
BVpS10.01
TBVpS5.48
PEG (NY)2.24
PEG (5Y)1.29
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROCE 18.98%
ROIC 14.15%
ROICexc 17.55%
ROICexgc 29.07%
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
FCFM 9.57%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
ROICexc(3y)15.86%
ROICexc(5y)10.93%
ROICexgc(3y)28.04%
ROICexgc(5y)19.36%
ROCE(3y)18.31%
ROCE(5y)12.72%
ROICexgc growth 3Y47.18%
ROICexgc growth 5Y16.9%
ROICexc growth 3Y46.83%
ROICexc growth 5Y30.42%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Debt/EBITDA 0.78
Cap/Depr 57.1%
Cap/Sales 3.93%
Interest Coverage 250
Cash Conversion 63.4%
Profit Quality 116.78%
Current Ratio 2.25
Quick Ratio 1.62
Altman-Z 3.65
F-Score6
WACC9.37%
ROIC/WACC1.51
Cap/Depr(3y)53.43%
Cap/Depr(5y)43.4%
Cap/Sales(3y)3.46%
Cap/Sales(5y)3.1%
Profit Quality(3y)155.68%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%
EBIT growth 1Y0.17%
EBIT growth 3Y40.57%
EBIT growth 5Y37.22%
EBIT Next Year52.58%
EBIT Next 3Y14.47%
EBIT Next 5Y9.48%
FCF growth 1Y-23.96%
FCF growth 3Y22.54%
FCF growth 5Y31.03%
OCF growth 1Y-12.01%
OCF growth 3Y21.57%
OCF growth 5Y30.48%

CHAMPIONX CORP / CHX FAQ

What is the ChartMill fundamental rating of CHAMPIONX CORP (CHX) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CHX.


Can you provide the valuation status for CHAMPIONX CORP?

ChartMill assigns a valuation rating of 4 / 10 to CHAMPIONX CORP (CHX). This can be considered as Fairly Valued.


What is the profitability of CHX stock?

CHAMPIONX CORP (CHX) has a profitability rating of 8 / 10.


Can you provide the expected EPS growth for CHX stock?

The Earnings per Share (EPS) of CHAMPIONX CORP (CHX) is expected to grow by 6.36% in the next year.


Is the dividend of CHAMPIONX CORP sustainable?

The dividend rating of CHAMPIONX CORP (CHX) is 3 / 10 and the dividend payout ratio is 24.7%.